NCT04638699

Brief Summary

Adequate, needs-oriented psycho-oncological care contributes to reducing the burden on cancer patients and their relatives and to improving the quality of life. There is still a need for clarification regarding the need and the determination of psychosocial needs. This multi-center study (3 centers: Hanover, Leipzig and Dresden) aims at a professionalization of psychosocial screening, in order to enable thus an exact and need-based allocation to psycho-oncological support. The optimization and professionalization of the psychosocial screening process shall be achieved by a training of oncological nursing and development of an interdisciplinary care algorithm. The aim is to examine whether "OptiScreen" increases the targeted and needs-based allocation to psycho-oncology.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
900

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 20, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

March 1, 2023

Status Verified

February 1, 2023

Enrollment Period

3.2 years

First QC Date

November 2, 2020

Last Update Submit

February 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of Psychological distress in cancer patients (CG vs. IG) and changes over time

    Distress Thermometer (NCCN Distress Thermometer)

    T0 (at hospital stay) and T1 (3 months later)

Secondary Outcomes (12)

  • Frequency and extent of depression in cancer patients (CG vs. IG) and changes over time

    T0 (at hospital stay) and T1 (3 months later)

  • Frequency and extent of anxiety in cancer patients (CG vs. IG) and changes over time

    T0 (at hospital stay) and T1 (3 months later)

  • Frequency and extent of supportive care needs in cancer patients (CG vs. IG) and changes over time

    T0 (at hospital stay) and T1 (3 months later)

  • Frequency and extent of fear of cancer recurrence in cancer patients (CG vs. IG) and changes over time

    T0 (at hospital stay) and T1 (3 months later)

  • Frequency and changes in quality of life in cancer patients (CG vs. IG) and changes over time

    T0 (at hospital stay) and T1 (3 months later)

  • +7 more secondary outcomes

Study Arms (2)

Phase 1 Survey of the actual state

NO INTERVENTION

Phase 2 Survey after the OptiScreen training

OTHER
Other: OptiScreen training

Interventions

Special psycho-oncological training for nursing staff to acquire basic knowledge about the experience of mental stress as well as diagnostics of psychosocial stress

Phase 2 Survey after the OptiScreen training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In-patients of the visceral oncology centers at the three locations

You may not qualify if:

  • severe physical, cognitive and/or language limitations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hannover Medical School

Hanover, Germany

RECRUITING

Study Officials

  • Tanja Zimmermann

    Hannover Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Tanja Zimmermann

Study Record Dates

First Submitted

November 2, 2020

First Posted

November 20, 2020

Study Start

April 1, 2020

Primary Completion

June 30, 2023

Study Completion

December 31, 2023

Last Updated

March 1, 2023

Record last verified: 2023-02

Locations